Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Embecta (EMBC) Gains from Investment Securities (2021 - 2026)

Embecta recorded quarterly Gains from Investment Securities of $4.5 million in Q1 2026, up 1025.0% quarter-over-quarter from $400000.0 in Q4 2025, and up 245.16% year-over-year from $1.3 million in Q1 2025.

Embecta's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $4.5 million for Q1 2026.

  • In Q1 2026, Gains from Investment Securities rose 245.16% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $5.7 million (up 90.0% YoY), while the FY2025 annual figure was $1.4 million, down 53.33% from the prior year.
  • Gains from Investment Securities came in at $4.5 million for Q1 2026 at Embecta, up from $400000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.1 million in Q2 2025 to a low of -$4.3 million in Q3 2025.
  • A 5-year average of $921428.6 and a median of $900000.0 in 2022 frame the typical range for Gains from Investment Securities.
  • Across the five-year window, Gains from Investment Securities sank 2250.0% in 2025 and soared 245.16% in 2026, its largest moves.
  • Embecta's Gains from Investment Securities stood at $900000.0 in 2022, then surged by 144.44% to $2.2 million in 2023, then surged by 68.18% to $3.7 million in 2024, then tumbled by 89.19% to $400000.0 in 2025, then surged by 1025.0% to $4.5 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods registered $4.5 million, $400000.0, and -$4.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Embecta 197.17 Mn 3.77 Mn 127.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.50 Mn
Mar 31, 2026 4.50 Mn
Dec 31, 2025 400,000.00
Dec 31, 2025 400,000.00
Sep 30, 2025 -4.30 Mn
Sep 30, 2025 -4.30 Mn
Jun 30, 2025 5.10 Mn
Jun 30, 2025 5.10 Mn
Mar 31, 2025 -3.10 Mn
Mar 31, 2025 -3.10 Mn
Dec 31, 2024 3.70 Mn
Dec 31, 2024 3.70 Mn
Sep 30, 2024 200,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 2.20 Mn
Jun 30, 2024 2.20 Mn
Mar 31, 2024 -1.60 Mn
Mar 31, 2024 -1.60 Mn
Dec 31, 2023 2.20 Mn
Dec 31, 2023 2.20 Mn
Sep 30, 2023 200,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 1.60 Mn
Jun 30, 2023 1.60 Mn
Mar 31, 2023 900,000.00
Mar 31, 2023 900,000.00
Dec 31, 2022 900,000.00
Dec 31, 2022 900,000.00
Jun 30, 2021 200,000.00
Jun 30, 2021 200,000.00